We are live on ! Find out more
BLTE

Belite Bio
BLTE

11 hedge funds and large institutions have $8.52M invested in Belite Bio in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

282% more capital invested

Capital invested by funds: $2.23M → $8.52M (+$6.29M)

0.43% more ownership

Funds ownership: 0.2% → 0.63% (+0.43%)

0% more funds holding

Funds holding: 11 → 11 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$6.41M
2
HF
HRT Financial
New York
+$234K
3
GI
GAMMA Investing
California
+$8.4K
4
Osaic Holdings
Osaic Holdings
Arizona
+$130

Top Sellers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
-$406K
2
Morgan Stanley
Morgan Stanley
New York
-$218K
3
CSS
Cubist Systematic Strategies
Connecticut
-$184K
4
Bank of America
Bank of America
North Carolina
-$70.2K
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$60.1K

BLTE Hedge Fund Activity: Q2 2024 in Review

11 of the 6,936 institutional investors tracked by Wall St. Rank reported a position in Belite Bio (BLTE) for Q2 2024, worth a combined $8.52M — up 282% from $2.23M a quarter earlier.

Fund positioning in BLTE was balanced in Q2 2024: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 6 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $6.41M. The largest seller was Marshall Wace, exiting entirely with an estimated $406K sold.

  • 11 institutional investors held Belite Bio (BLTE) as of Q2 2024, unchanged from Q1 2024.
  • Funds reported $8.52M of Belite Bio stock for Q2 2024, up 282% quarter-over-quarter.
  • 2 funds opened new Belite Bio positions in Q2 2024 and 2 closed out, a net change of 0 holders.
  • The largest Belite Bio buyer in Q2 2024 was Armistice Capital, an estimated $6.41M added.
  • The largest Belite Bio seller in Q2 2024 was Marshall Wace, an estimated $406K sold.

Based on aggregated 13F filings for Q2 2024.